Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
This review covers the literature between 1989 and 2007 on studies relevant to the neuro-oncology usage of eflornithine (α-difluoromethylornithine), an oral agent that irreversibly inhibits the enzyme ornithine decarboxylase. It covers the use of eflornithine, alone or in combination, to treat high-...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2018-04-01
|
| Schriftenreihe: | CNS Oncology |
| Schlagworte: | |
| Online-Zugang: | https://www.futuremedicine.com/doi/10.2217/cns-2017-0031 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|